Neurotech International Limited

ASX:NTI.AX

0.1 (AUD) • At close April 12, 2024
Bedrijfsnaam Neurotech International Limited
Symbool NTI.AX
Munteenheid AUD
Prijs 0.105
Beurswaarde 96,325,845
Dividendpercentage 0%
52-weken bereik 0.031 - 0.125
Industrie Medical Devices
Sector Healthcare
CEO Dr. Alexandra Andrews
Website https://www.neurotechinternational.com

An error occurred while fetching data.

Over Neurotech International Limited

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the

Vergelijkbare Aandelen

Resonance Health Limited logo

Resonance Health Limited

RHT.AX

0.075 AUD

IDT Australia Limited logo

IDT Australia Limited

IDT.AX

0.1 AUD

Alterity Therapeutics Limited logo

Alterity Therapeutics Limited

ATH.AX

0.005 AUD

Althea Group Holdings Limited logo

Althea Group Holdings Limited

AGH.AX

0.032 AUD

Lumos Diagnostics Holdings Limited logo

Lumos Diagnostics Holdings Limited

LDX.AX

0.058 AUD

Imricor Medical Systems, Inc. logo

Imricor Medical Systems, Inc.

IMR.AX

0.55 AUD

Cryosite Limited logo

Cryosite Limited

CTE.AX

0.7 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)